Jiangsu Hengrui Medicine Co., Ltd. (HKG:1276)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
56.30
-0.60 (-1.05%)
At close: Jun 20, 2025, 4:00 PM HKT

Jiangsu Hengrui Medicine Company Description

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes drugs in China and internationally.

The company develops antineoplastic drugs; surgery medications; medicines for oncology, autoimmune diseases, pain management, metabolic diseases, cardiovascular diseases, infectious diseases, respiratory system diseases, hematological diseases, neurological diseases, and ophthalmology, etc.; analgesia and anesthesia products; and contrast agents.

It is also involved in technical consulting; training; investment advisory; technology development; project; information; and investing services, as well as the import and export of pharmaceutical products.

Jiangsu Hengrui Medicine Co., Ltd. was founded in 1970 and is headquartered in Lianyungang City, China.

Jiangsu Hengrui Medicine Co., Ltd.
Country China
Founded 1970
Industry Pharmaceutical Preparations
Employees 20,238
CEO Ji Feng

Contact Details

Address:
No. 38, Huanghe Road
Lianyungang City, Liaoning Province 222000
China
Phone 86 40 0828 3900
Website hengrui.com

Stock Details

Ticker Symbol 1276
Exchange Hong Kong Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
SIC Code 2834

Key Executives

Name Position
Ji Feng Chief Executive Officer
Kin Chun Lau Chief Financial Officer
Ji Feng Chief Operating Officer